May 25, 2016 Cellectar Biosciences Announces USPTO Issues Patent for New Phospholipid Drug Conjugate (PDC) with Paclitaxel Learn More
May 24, 2016 Cellectar Biosciences to Present at the 5th Annual SeeThru Equity Microcap Investor Conference Learn More
May 20, 2016 Cellectar Biosciences Patent Application for Phospholipid-Ether Analogs as Cancer Targeting Drug Vehicles Published by USPTO Learn More